AU2005901879A0 - Methods and compositions for treatment of hematologic cancers - Google Patents

Methods and compositions for treatment of hematologic cancers

Info

Publication number
AU2005901879A0
AU2005901879A0 AU2005901879A AU2005901879A AU2005901879A0 AU 2005901879 A0 AU2005901879 A0 AU 2005901879A0 AU 2005901879 A AU2005901879 A AU 2005901879A AU 2005901879 A AU2005901879 A AU 2005901879A AU 2005901879 A0 AU2005901879 A0 AU 2005901879A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
hematologic cancers
hematologic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005901879A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viralytics Ltd
Original Assignee
Psiron Ltd
Filing date
Publication date
Application filed by Psiron Ltd filed Critical Psiron Ltd
Publication of AU2005901879A0 publication Critical patent/AU2005901879A0/en
Priority to AU2005274617A priority Critical patent/AU2005274617B2/en
Priority to CA2577692A priority patent/CA2577692C/en
Priority to US11/660,458 priority patent/US8236298B2/en
Priority to CN2005800347637A priority patent/CN101065144B/en
Priority to PCT/AU2005/001257 priority patent/WO2006017914A1/en
Priority to JP2007526129A priority patent/JP5054522B2/en
Priority to EP05773382.6A priority patent/EP1793851B1/en
Priority to KR1020077006358A priority patent/KR101295733B1/en
Priority to JP2012055445A priority patent/JP2012144549A/en
Priority to US13/555,615 priority patent/US20130164330A1/en
Priority to US14/579,826 priority patent/US20150273002A1/en
Abandoned legal-status Critical Current

Links

AU2005901879A 2004-08-20 2005-04-14 Methods and compositions for treatment of hematologic cancers Abandoned AU2005901879A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
KR1020077006358A KR101295733B1 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
PCT/AU2005/001257 WO2006017914A1 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
CA2577692A CA2577692C (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
US11/660,458 US8236298B2 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
CN2005800347637A CN101065144B (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
AU2005274617A AU2005274617B2 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
JP2007526129A JP5054522B2 (en) 2004-08-20 2005-08-22 Methods and compositions for treating blood cancer
EP05773382.6A EP1793851B1 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers
JP2012055445A JP2012144549A (en) 2004-08-20 2012-03-13 Method and composition for treatment of hematologic cancer
US13/555,615 US20130164330A1 (en) 2004-08-20 2012-07-23 Methods and Compositions for Treatment of Hematologic Cancers
US14/579,826 US20150273002A1 (en) 2004-08-20 2014-12-22 Methods and compositions for treatment of hematologic cancers

Publications (1)

Publication Number Publication Date
AU2005901879A0 true AU2005901879A0 (en) 2005-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP1793851A4 (en) Methods and compositions for treatment of hematologic cancers
WO2007081751A9 (en) Compositions and methods for the treatment of cancer
EP2671581B8 (en) Compositions and methods for treating cancer
EP1663259A4 (en) Compositions and methods for treatment of cancer
EP1969147A4 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
EP1874342A4 (en) Compositions and methods for cancer immunotherapy
EP1812031A4 (en) Compositions and methods for modification of biomolecules
EP1838330A4 (en) Treatment of solid cancers
EP2049151A4 (en) Methods and compositions for the treatment of cancer
IL190520A0 (en) Compositions and methods for treatment of autoimmune
IL176919A0 (en) Methods and compositions for treating cancer
EP1812596A4 (en) Treatment of cancer and compositions
EP1855662A4 (en) Methods and compositions for treating cancer
HK1164767A1 (en) Compounds and methods for the treatment of cancer
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1912630A4 (en) Compositions and methods for the reduction of post-operative pain
EP1904088A4 (en) Compositions and methods for the treatment of cancer
AU2003219160A1 (en) Methods and compositions for the treatment of cancer
ZA200702269B (en) Methods and compositions for treatment of hematologic cancers
ZA200709959B (en) Triazine compounds and compositions thereof for the treatment of cancers
ZA200808600B (en) Methods and compositions for the detection and treatment of cancers
GB0504657D0 (en) Compositions and methods of treatment
AU2005901879A0 (en) Methods and compositions for treatment of hematologic cancers
ZA200710476B (en) Methods and compositions for the treatment of pain
AU2005904259A0 (en) Compositions and methods of treatment